Gyre Therapeutics Inc. (GYRE) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $8.52
• Market Cap: $833.28M
• P/E Ratio: 216.25
• EPS: $0.04
• 52-Week High: $13.75
• 52-Week Low: $6.11

Market Sentiment

Gyre Therapeutics Inc. currently has a Neutral sentiment score of 0.05.

About Gyre Therapeutics Inc.

None

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Gyre Therapeutics Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does GYRE pay dividends?

Gyre Therapeutics Inc. (GYRE) does not currently pay a regular dividend.

What is GYRE's P/E ratio?

Gyre Therapeutics Inc. has a price-to-earnings (P/E) ratio of 216.25.

What is GYRE's market cap?

Gyre Therapeutics Inc. (GYRE) has a market capitalization of $833.28M with a current stock price of $8.52.